Clinical Trial Update: Adjuvant Pancreatic Therapy Guided by MRD [NA]

View source ↗

Summary

A registered clinical trial investigating adjuvant pancreatic therapy guided by minimal residual disease (MRD) in resectable pancreatic adenocarcinoma; currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Snippet

Sponsor: Ruijin Hospital | Conditions: Pancreatic Adenocarcinoma Resectable | NA | Status: RECRUITING